Motif ID: RUNX3_BCL11A
Z-value: 0.818
Transcription factors associated with RUNX3_BCL11A:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
BCL11A | ENSG00000119866.16 | BCL11A |
RUNX3 | ENSG00000020633.14 | RUNX3 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
BCL11A | hg19_v2_chr2_-_60780607_60780634 | -0.47 | 1.9e-02 | Click! |
RUNX3 | hg19_v2_chr1_-_25256368_25256476 | 0.44 | 3.2e-02 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.1 | GO:1902228 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.4 | 1.5 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.4 | 4.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.4 | 1.1 | GO:2000866 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
0.3 | 1.3 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
0.3 | 0.8 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.2 | 1.0 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.2 | 1.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 2.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.2 | 2.2 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.2 | 2.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.6 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.2 | 0.6 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) positive regulation of oocyte maturation(GO:1900195) |
0.2 | 1.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 1.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 0.5 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.2 | 0.5 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 0.6 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.7 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.1 | 0.4 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
0.1 | 0.9 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.3 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.1 | 0.6 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.1 | 0.3 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.1 | 0.3 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
0.1 | 0.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.4 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.1 | 0.4 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
0.1 | 0.6 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 0.5 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.1 | 0.3 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.1 | 0.3 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.1 | 0.5 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.1 | 0.3 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.1 | 0.7 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 0.5 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.1 | 0.6 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.1 | 0.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.1 | 0.3 | GO:0050894 | determination of affect(GO:0050894) |
0.1 | 0.2 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.1 | 0.2 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.1 | 1.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.3 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.1 | 0.2 | GO:1903413 | cellular response to mycotoxin(GO:0036146) glycoside transport(GO:1901656) cellular response to bile acid(GO:1903413) |
0.1 | 1.2 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 0.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.2 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.1 | 0.2 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 2.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.2 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
0.1 | 0.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.4 | GO:0051414 | response to cortisol(GO:0051414) |
0.1 | 0.5 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.1 | 0.5 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.5 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.1 | 0.2 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.1 | 0.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 0.2 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.1 | 0.4 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.1 | 0.3 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.1 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
0.0 | 0.9 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.7 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.2 | GO:0097106 | postsynaptic density organization(GO:0097106) |
0.0 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.2 | GO:1990523 | bone regeneration(GO:1990523) |
0.0 | 0.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.0 | 0.1 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.0 | 0.4 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.0 | 0.1 | GO:0030185 | nitric oxide transport(GO:0030185) regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.0 | 0.8 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.2 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.8 | GO:0097320 | membrane tubulation(GO:0097320) |
0.0 | 0.2 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.0 | 0.1 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.0 | 0.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.3 | GO:0072513 | semicircular canal morphogenesis(GO:0048752) positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.0 | 0.4 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.4 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 0.5 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.9 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.1 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.4 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.0 | 0.2 | GO:0070836 | caveola assembly(GO:0070836) |
0.0 | 0.5 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.5 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.0 | 0.2 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) Golgi disassembly(GO:0090166) |
0.0 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.0 | 0.3 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 2.7 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.1 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.1 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
0.0 | 0.1 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.0 | 0.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.1 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.1 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.0 | 0.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.0 | 0.1 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.0 | 0.4 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.0 | 0.5 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.5 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.1 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.0 | 0.1 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.0 | 0.2 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.2 | GO:1904869 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
0.0 | 0.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.4 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.0 | 0.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.4 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.3 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.2 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.0 | 0.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.0 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.6 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.0 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.0 | 0.4 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.0 | 0.1 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.6 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.2 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.5 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 0.2 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.2 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.0 | 0.6 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.0 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.0 | 0.2 | GO:0007625 | grooming behavior(GO:0007625) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 2.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.2 | 0.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.4 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.1 | 0.9 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.1 | 1.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 2.2 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 1.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.3 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.1 | 0.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 0.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.6 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.1 | 1.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 3.4 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.2 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.0 | 0.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.1 | GO:0097059 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
0.0 | 5.4 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.1 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.4 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.5 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.0 | 0.8 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.6 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.3 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 1.2 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.3 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.1 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 2.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 4.5 | GO:1990254 | keratin filament binding(GO:1990254) |
0.4 | 1.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 2.0 | GO:0050436 | microfibril binding(GO:0050436) |
0.3 | 2.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 0.8 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.2 | 2.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.6 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.2 | 1.6 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 1.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.5 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.1 | 0.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 1.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.3 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.1 | 0.5 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 0.3 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.1 | 0.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.5 | GO:0042835 | BRE binding(GO:0042835) |
0.1 | 0.3 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.1 | 0.8 | GO:0004075 | biotin carboxylase activity(GO:0004075) biotin binding(GO:0009374) |
0.1 | 0.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 0.2 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.1 | 1.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.5 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.2 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.1 | 0.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.1 | 0.2 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.0 | 0.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 1.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.2 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.0 | 0.2 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 0.2 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.0 | 1.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 1.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.4 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.3 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.0 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
0.0 | 0.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.2 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.6 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 1.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.0 | 2.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.0 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.1 | GO:0030395 | lactose binding(GO:0030395) |
0.0 | 0.1 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.0 | 0.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 0.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 2.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.2 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.0 | 0.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 1.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.0 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.0 | 0.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.2 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 7.4 | PID_AURORA_B_PATHWAY | Aurora B signaling |
0.1 | 3.1 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 1.9 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 2.2 | PID_AVB3_OPN_PATHWAY | Osteopontin-mediated events |
0.0 | 1.7 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.9 | PID_FGF_PATHWAY | FGF signaling pathway |
0.0 | 2.6 | PID_TCR_PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 1.2 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 2.6 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.4 | PID_ALK2_PATHWAY | ALK2 signaling events |
0.0 | 0.8 | PID_RAS_PATHWAY | Regulation of Ras family activation |
0.0 | 0.1 | ST_INTERFERON_GAMMA_PATHWAY | Interferon gamma pathway. |
0.0 | 0.6 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
0.0 | 0.2 | ST_IL_13_PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.6 | PID_GMCSF_PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.1 | PID_IL12_STAT4_PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.5 | PID_EPHRINB_REV_PATHWAY | Ephrin B reverse signaling |
0.0 | 0.3 | PID_ECADHERIN_KERATINOCYTE_PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.5 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.0 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
0.0 | 0.2 | SA_B_CELL_RECEPTOR_COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.5 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.5 | SIG_CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.2 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
0.0 | 0.7 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
0.0 | 0.4 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.6 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.4 | PID_INTEGRIN_CS_PATHWAY | Integrin family cell surface interactions |
0.0 | 0.4 | PID_CXCR3_PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.8 | PID_LKB1_PATHWAY | LKB1 signaling events |
0.0 | 0.4 | PID_IL6_7_PATHWAY | IL6-mediated signaling events |
0.0 | 0.2 | PID_SYNDECAN_3_PATHWAY | Syndecan-3-mediated signaling events |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.6 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 4.1 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.0 | REACTOME_PURINE_CATABOLISM | Genes involved in Purine catabolism |
0.1 | 2.4 | REACTOME_KINESINS | Genes involved in Kinesins |
0.1 | 0.9 | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.9 | REACTOME_KERATAN_SULFATE_DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 1.7 | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 1.7 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.2 | REACTOME_ENDOGENOUS_STEROLS | Genes involved in Endogenous sterols |
0.0 | 1.0 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.2 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.6 | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.7 | REACTOME_ENOS_ACTIVATION_AND_REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.3 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.8 | REACTOME_STEROID_HORMONES | Genes involved in Steroid hormones |
0.0 | 0.3 | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.4 | REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.5 | REACTOME_BETA_DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.4 | REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.5 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.3 | REACTOME_P2Y_RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.1 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.1 | REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.4 | REACTOME_IL_RECEPTOR_SHC_SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.7 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.2 | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |